Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final data from three clinical trials of CardiAMP cell therapy, with the latest Phase III results presented ...
At AD/PD 2026, Roche announced that patients treated with prasinezumab for five years demonstrated a sustained slowing of ...
Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at ...
AEMD READ THE FULL AEMD RESEARCH REPORT DSMB recommends AEMD progress clinical trial to the final third cohort Aethlon Medical (NASDAQ: AEMD) announced today that the independent Data Safety ...
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
ABS-201 Phase I/IIa progress, early safety/PK, AGA & endometriosis timelines, cash runway & catalysts—read now.
All six participants tolerated surgical and intra-cochlear SENS-501 administration well, with no serious adverse events ...
ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...
TenoMiR to Progress to Phase 3 Study for Lateral Epicondylitis, Making it One of the Most Advanced microRNA Clinical Programs GLASGOW, Scotland, March 19, 2026 (GLOBE NEWSWIRE) -- Causeway ...
New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...
Abivax SA ABVX is preparing to raise capital following the release of key clinical trial data in June, signaling a preference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results